Grants and Contracts per year
Search results
-
Active
-
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-Mutated Advanced Epithelial Ovarian Cancer (EOC)
Gynecological Oncology Group Foundation Incorporated
2/27/20 → 8/24/24
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Gynecological Oncology Group Foundation Incorporated
11/15/19 → 1/16/24
Project: Research project
-
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel with or without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Newly Diagnosed Subjects with Previously Untreated Stages III or IV High-Grade Serious Epithelial Ovarian,
Ueland, F., Baldwin Branch, L., Desimone, C. & Miller, R.
Gynecological Oncology Group Foundation Incorporated
12/23/15 → 7/4/24
Project: Research project
-
Member Institution Purchased Service Agreement
Miller, R. & Romond, E.
NRG Oncology Foundation Incorporated
3/1/14 → 1/4/24
Project: Research project
-
Finished
SUPPLEMENT: Diversity in Cancer Research Supplement: University of Kentucky
O'Connor, K., Awuah, S., Bocklage, T., Cavnar, M., Chambers, M., Gao, T., Gentry, M., Goellner, E., Kuhs, K., Miller, R., Wang, X. & Williams, L.
1/1/22 → 12/31/22
Project: Research project
-
Diversity in Cancer Research (DICR) Markey STRONG Scholars Program
O'Connor, K., Awuah, S., Bocklage, T., Cavnar, M., Chambers, M., Gao, T., Goellner, E., Kuhs, K., Miller, R., Vanderford, N., Wang, X., Williams, L. & Fondufe-Mittendorf, Y.
5/5/21 → 5/4/22
Project: Research project
-
A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovar
Gynecological Oncology Group Foundation Incorporated
7/28/20 → 7/15/21
Project: Research project
-
The Role of Multilevel Healthcare Access Dimensions in Ovarian Cancer Disparities
Akinyemiju, O., Durbin, E. B., Huang, B., Miller, R. & Tucker, T.
12/3/18 → 1/31/19
Project: Research project
-
CCSG Pilot: Selection of Personalized Cancer Therapies by Evaluating Intra-tumoral Heterogeneity and Phylogentic Analysis
Kolesar, J., Evers, B. M., Miller, R. & Wang, C.
7/9/18 → 4/8/20
Project: Research project
-
Changes in Fallopian Tube Epithelium Associated with Ovarian Cancer
Miller, R. & Baldwin Branch, L.
Lexington Cancer Foundation Incorporated
1/1/18 → 6/30/19
Project: Research project
-
Smoking Cessation Treatment Delivery to Cervical Cancer Survivors with Low Social Resources: A Pilot RCT
Burris, J., Miller, R., Shelton, B., Eddens, K. & Studts, J.
7/1/17 → 6/30/20
Project: Research project
-
GOG-3011 (0403) FORWARD1: A Randomized, Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Adults with Folate Receptor a-positive Advanced
Gynecological Oncology Group Foundation Incorporated
6/8/17 → 3/14/19
Project: Research project
-
Phase 1-2 Study of MEDI4736 Alone or In Combination With ADXS11-001 In Recurrent/Persistent or Metastatic Cervical or HPV + Head & Neck Cancer
10/21/16 → 10/20/18
Project: Research project
-
Changes in Fallopian Tube Epithelium Associated with Ovarian Cancer
Miller, R. & Baldwin Branch, L.
Lexington Cancer Foundation Incorporated
7/1/16 → 11/1/19
Project: Research project
-
UM1 Supplement for Early Therapeutic Trails with Phase 2 Intent
Arnold, S., Hildebrandt, G., Kolesar, J., Mathew, A., McGarry, R., Miller, R., Saeed, H., Villano, J. & Wang, P.
3/1/16 → 2/28/18
Project: Research project
-
UM1 Supplement for Early Therapeutic Trails with Phase 2 Intent
Arnold, S., Hildebrandt, G., Kolesar, J., Mathew, A., McGarry, R., Miller, R., Saeed, H., Villano, J. & Wang, P.
3/1/16 → 2/28/18
Project: Research project
-
Chemotherapy Induced Cognitive Impairment: A novel prospective study of the cognitive effects of platinum/taxane-based chemotherapy in ovarian cancer patients
Miller, R., Anderson Mooney, A., Butterfield, D. A., Jiang, Y. & St Clair, D.
Army Medical Research and Materiel Command
9/1/15 → 2/28/19
Project: Research project
-
Neoadjuvant Chemotherapy in theTreatment of Advanced Stage Ovarian Cancer
Lexington Cancer Foundation Incorporated
10/1/14 → 9/30/15
Project: Research project
-
Neoadjuvant Chemotherapy in theTreatment of Advanced Stage Ovarian Cancer (2013 award)
Lexington Cancer Foundation Incorporated
12/1/13 → 9/30/14
Project: Research project
-
Supplement: University of Kentucky Markey Cancer Center Support Grant CCITLA (Rachel Miller)
7/8/13 → 6/30/18
Project: Research project
-
Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Lexington Cancer Foundation Incorporated
12/1/12 → 11/30/13
Project: Research project
-
Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars
Curry, T., Coker, A., Eddens, K., Fallin-Bennett, A., Martin, C., Miller, R., Moga, D., Reese, S. & Snell-Rood, C.
National Institute on Drug Abuse
8/1/12 → 7/31/16
Project: Research project
-
Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars
Curry, T., Coker, A., Eddens, K., Fallin-Bennett, A., Martin, C., Miller, R., Moga, D., Reese, S. & Snell-Rood, C.
National Institute on Drug Abuse
8/1/12 → 7/31/17
Project: Research project
-
Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars
Curry, T., Brouwer, E., Coker, A., Martel, M., Martin, C., Miller, R. & Vanderpool, R.
National Institute on Drug Abuse
8/1/12 → 7/31/15
Project: Research project
-
Neoadjuvant Platinum-Based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol
Lexington Cancer Foundation Incorporated
11/17/11 → 11/16/12
Project: Research project
-
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gencitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Promary Peritoneal, or Fallopian Tube Carcinoma
Ueland, F., Depriest, P., Desimone, C., Miller, R., Saunders, B. & VanNagell, J.
9/25/07 → 6/30/14
Project: Research project